AJP - Heart and Circulatory Physiology, Vol 270, Issue 4 1149-H1158, Copyright © 1996 by American Physiological Society

ARTICLES

Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells

L. Descamps, M. P. Dehouck, G. Torpier and R. Cecchelli
Institut National de la Sante et de la Recherche Medicale U325-Service d'Etude et de Recherche sur les Lipoproteines et l'Atherosclerose, Institut Pasteur, Lille, France.

A cell culture model of the blood-brain barrier consisting of a coculture of bovine brain capillary endothelial cells (BBCECs) and astrocytes has been used to examine the mechanism of iron transport to the brain. Binding experiments showed that BBCECs express 35,000 high-affinity (concn at 50% receptor saturation = 11.3 +/- 2.1 nM) transferin (Tf) receptors per cell. In contrast to apo-transferrin (apoTf) we observed a specific transport of holo-transferrin (holoTf) across BBCECs. This transport was inhibited completely at low temperature. Moreover, the anti-Tf receptor antibody (OX-26) competitively inhibited holoTf uptake by BBCECs. Pulse-chase experiments demonstrated that only 10% of Tf was recycled to the luminal side of the cells, whereas the majority of Tf was transcytosed to the abluminal side; double-labeling experiments clearly demonstrated that iron crosses BBCECs bound to Tf. No intraendothelial degradation of Tf was observed, suggesting that the intraendothelial pathway through BBCECs bypasses the lysosomal compartment. These results clearly show that the iron-Tf complex is transcytosed across brain capillary endothelial cells by a receptor-mediated pathway without any degradation.

This article has been cited by other articles:

				P. L. TUMA and A. L. HUBBARD Transcytosis: Crossing Cellular Barriers Physiol Rev, July 1, 2003; 83(3): 871 - 932. [Abstract] [Full Text] [PDF]

				H. J. Lee, B. Engelhardt, J. Lesley, U. Bickel, and W. M. Pardridge Targeting Rat Anti-Mouse Transferrin Receptor Monoclonal Antibodies through Blood-Brain Barrier in Mouse J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1048 - 1052. [Abstract] [Full Text]

				L. Fenart, A. Casanova, B. Dehouck, C. Duhem, S. Slupek, R. Cecchelli, and D. Betbeder Evaluation of Effect of Charge and Lipid Coating on Ability of 60-nm Nanoparticles to Cross an In Vitro Model of the Blood-Brain Barrier J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1017 - 1022. [Abstract] [Full Text]

				D. Wu and W. M. Pardridge Pharmacokinetics and Blood-Brain Barrier Transport of an Anti-Transferrin Receptor Monoclonal Antibody (OX26) in Rats after Chronic Treatment with the Antibody Drug Metab. Dispos., September 1, 1998; 26(9): 937 - 939. [Abstract] [Full Text]

				B. Dehouck, L. Fenart, M.-P. Dehouck, A. Pierce, G. Torpier, and R. Cecchelli A New Function for the LDL Receptor: Transcytosis of LDL across the Blood-Brain Barrier J. Cell Biol., August 25, 1997; 138(4): 877 - 889. [Abstract] [Full Text] [PDF]